DNA Dec 2023 3.000 call
| Previous Close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0000 |
| Ask | 0.0500 |
| Strike | 3.00 |
| Expire Date | 2023-12-15 |
| Day's Range | 0.0500 - 0.0500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3.5k |
IPO-Edge.comFreight Farms Emerges as Global AgTech Leader with Small-Scale Solutions
Freight Farms merging with blank-check company Agrinam Acquisition Corp. (TSX: AGRI.U) AgTech startup provides hydroponic farming solutions, with over 600 farms in operation across 40 countries Has largest network of […]
PR NewswireVivici Selects Ginkgo Bioworks to Extend Their Range of Novel Dairy Proteins
Vivici BV, an innovative B2B ingredients startup company using precision fermentation to make animal-free dairy proteins, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new partnership. Through this collaboration, Vivici will leverage Ginkgo's extensive capabilities in strain engineering, optimization and performance, to develop and commercialize a next generation of functional alternative protein.
GlobeNewswireXWELL, Inc. Reports Third Quarter 2023 Results
XWELL, Inc. Brands XWELL, Inc. Brands Airport Spas Deliver Strong 39% Year-Over-Year Q3 Revenue GrowthNaples Wax Center Acquisition Accelerates Future Off-Airport Growth OpportunitiesFurther Airport Spa Expansion Internationally NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the third quarter ended September 30, 2023. Financial and Business Highlights: The Compa
